About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- mifepristone
- Procedure number
- PSUSA/00002060/202305
- Regulatory outcome
- Variation
Documents
Mifepristone : List of nationally authorised medicinal products - PSUSA/00002060/202305
English (EN) (196.93 KB - PDF)
Mifepristone : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002060/202305
English (EN) (76.38 KB - PDF)
български (BG) (109.06 KB - PDF)
español (ES) (80.29 KB - PDF)
čeština (CS) (177.4 KB - PDF)
dansk (DA) (91.92 KB - PDF)
Deutsch (DE) (83.94 KB - PDF)
eesti keel (ET) (74.96 KB - PDF)
ελληνικά (EL) (78.16 KB - PDF)
français (FR) (141.73 KB - PDF)
hrvatski (HR) (100.92 KB - PDF)
íslenska (IS) (158.33 KB - PDF)
italiano (IT) (85.88 KB - PDF)
latviešu valoda (LV) (166.77 KB - PDF)
lietuvių kalba (LT) (81.38 KB - PDF)
magyar (HU) (75.6 KB - PDF)
Malti (MT) (207.07 KB - PDF)
Nederlands (NL) (86.27 KB - PDF)
norsk (NO) (35.75 KB - PDF)
polski (PL) (78.61 KB - PDF)
português (PT) (84.69 KB - PDF)
română (RO) (75.65 KB - PDF)
slovenčina (SK) (82 KB - PDF)
Suomi (FI) (85.21 KB - PDF)
svenska (SV) (92.81 KB - PDF)